Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of ExoBDNF Lactic Acid Bacteria Supplement on Cognitive Functions, Sleep and Psychological Outcomes: An Open-label Trial

NCT06968299 is registered in ClinicalTrials.gov with SunWay Biotech Co., LTD. as lead sponsor.

NCT NCT06968299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06968299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of ExoBDNF Lactic Acid Bacteria Supplement on Cognitive Functions, Sleep and Psychological Outcomes: An Open-label Trial
Lead sponsor
SunWay Biotech Co., LTD.
Phase
Not applicable
Overall status
Recruiting
Start date
May 20, 2025
Completion date
December 30, 2025
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive function abnormal, cognitive functions perceptual disturbances, psychological, sleep